Concepedia

Remco J. Molenaar

RJ

Statistics

Publications

32

Citations

1.9K

H-Index

25

Active since

2011

Affiliations

Amsterdam UMC Location University of Amsterdam(Current)

University of Amsterdam

Radboud University Nijmegen

National Institute of Biology

Amsterdam University Medical Centers

Remco J. Molenaar is an author at Amsterdam UMC Location University of Amsterdam specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2011–2021

32

Publications

32

The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone

Remco J. Molenaar, Dagmar Verbaan, Simona Lamba et al. · Neuro-Oncology · 2014 · 211 citations · Full text

, , +17

Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid Cancer

Remco J. Molenaar, Surbhi Sidana, Tomas Radivoyevitch et al. · Journal of Clinical Oncology · 2017 · 155 citations · Full text

, , +16

Radioprotection of <i>IDH1</i> -Mutated Cancer Cells by the IDH1-Mutant Inhibitor AGI-5198

Remco J. Molenaar, Dennis Botman, Myrthe A J Smits et al. · Cancer Research · 2015 · 144 citations

, , +17

<i>IDH1/2</i> Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant Inhibitors

Remco J. Molenaar, Tomas Radivoyevitch, Yasunobu Nagata et al. · Clinical Cancer Research · 2018 · 104 citations · Full text

, , +13

Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasms

Remco J. Molenaar, Swapna Thota, Yasunobu Nagata et al. · Leukemia · 2015 · 91 citations · Full text

, , +17

1–5 of 32